Gold hit fresh record highs on Thursday as investors sought a refuge from the turbulence surrounding trade tensions between ...

Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...

Beans such as black beans, kidney beans, and chickpeas can be added to salads, soups, stews, and grain bowls for an extra ...

Pfizer has encountered many setbacks in its quest to launch a medicine that could rival Wegovy and Zepbound. One of its ...

Last year, the National Health Commission and other departments launched the "Weight Management Year" initiative, aiming to ...

After reviewing all the data and considering input from regulators, Pfizer decided to discontinue the danuglipron program.

Tributyrin is a type of postbiotic that plays a vital role in maintaining gut health. It helps strengthen the gut barrier, ...

A new weight-loss pill taken daily could compete with injections like Ozempic, research suggests. Patients, who all were ...

The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of ...

A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...

In Australia, Ozempic is approved for the treatment of type 2 diabetes, while Wegovy is approved for weight management. Both ...

Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.